Circular Genomics launched the world's-first circular RNA biomarker-based MindLight - Antidepressant Response Test. Great work by the team! We are excited to see how they will continue to advance precision medicine in mental health.
Introducing Circular Genomics' MindLight™, the first circular RNA-based assay designed to predict whether a patient with #depression, also known as major depressive disorder, will respond to #SSRI antidepressant treatment. MindLight, a simple, biomarker-based blood test that can be taken at a physician’s office or lab, can help doctors determine if SSRI medication will be beneficial, and patients can start a personalized and effective treatment plan within just one week. Learn more about MindLight: https://hubs.la/Q02PZxK20 #MindLight #MajorDepressiveDisorder #AntidepressantTreatment #CircRNA